Free Trial

Biofrontera (BFRIW) 10K Form and Latest SEC Filings 2026

Biofrontera logo
$0.02 -0.01 (-27.06%)
As of 05/14/2026 03:10 PM Eastern

Latest Biofrontera SEC Filings & Recent Activity

Biofrontera (NASDAQ:BFRIW) has submitted 217+ documents to the U.S. Securities and Exchange Commission (SEC) since 2021. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. The most recent filing was a Form 8-K submitted on May 14, 2026.

Form 4
Biofrontera Inc. Reports Ownership Change on Mar. 6, 2026

Form 4 filings disclose changes in stock ownership by company insiders, including purchases, sales, grants, and option exercises.

View insider ownership

8-K
Biofrontera Files Current Report on May. 14, 2026

An 8-K is filed when a material corporate event occurs, such as an acquisition, leadership change, or financial update.

View filing

10-K
Biofrontera Files Annual Report on Mar. 19, 2026

The 10-K contains Biofrontera's audited financial statements, revenue, earnings, and risk factors for the prior fiscal year.

View earnings history

Biofrontera SEC Filing History

Browse Biofrontera's complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
05/14/2026 7:00 AM
Biofrontera (1858685) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/19/2026 3:15 PM
Biofrontera (1858685) Filer
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/19/2026 8:35 AM
Biofrontera (1858685) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/09/2026 8:20 AM
Biofrontera (1858685) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2026 8:25 PM
Biofrontera (1858685) Issuer
BORER JOHN J III (1406217) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2026 8:26 PM
Biofrontera (1858685) Issuer
Jones George Patrick (2085560) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2026 8:28 PM
Biofrontera (1858685) Issuer
Hoffman Beth J. (1885321) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2026 8:29 PM
Biofrontera (1858685) Issuer
Lanckriet Heikki (1990267) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2026 8:30 PM
Biofrontera (1858685) Issuer
Leffler Eugene Frederick (1952347) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2026 8:31 PM
Biofrontera (1858685) Issuer
Luebbert Hermann (1886492) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2026 8:33 PM
Biofrontera (1858685) Issuer
Weber Kevin Daniel (1916746) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2026 8:20 AM
Biofrontera (1858685) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/11/2026 10:31 AM
Biofrontera (1858685) Subject
Rosalind Advisors, Inc. (1622627) Filed by
Form SCHEDULE 13G/A
02/09/2026 8:20 AM
Biofrontera (1858685) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/28/2026 1:10 PM
Biofrontera (1858685) Subject
HIRSCHMAN ORIN (1131362) Filed by
Form SCHEDULE 13G/A
01/13/2026 7:35 AM
Biofrontera (1858685) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2026 3:30 PM
Biofrontera (1858685) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/21/2025 11:15 PM
Biofrontera (1858685) Filer
Form EFFECT
12/05/2025 4:15 PM
Biofrontera (1858685) Filer
Form S-1
Registration statement under Securities Act of 1933  
11/13/2025 7:30 AM
Biofrontera (1858685) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2025 3:31 PM
Biofrontera (1858685) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/12/2025 1:52 PM
Biofrontera (1858685) Subject
Rosalind Advisors, Inc. (1622627) Filed by
Form SCHEDULE 13G/A
11/07/2025 7:05 AM
Biofrontera (1858685) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/24/2025 4:29 PM
Biofrontera (1858685) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/23/2025 7:50 AM
Biofrontera (1858685) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2025 7:53 AM
Biofrontera (1858685) Issuer
Link Christian Alexander Ansgar (2088822) Reporting
Form 3
Initial statement of beneficial ownership of securities  
09/30/2025 7:42 AM
Biofrontera (1858685) Issuer
DELPHI UNTERNEHMENSBERATUNG AKTIENGESELLSCHAFT (1571070) Reporting
Form 3
Initial statement of beneficial ownership of securities  
09/30/2025 7:47 AM
Biofrontera (1858685) Issuer
VV Beteiligungen Aktiengesellschaft (1571058) Reporting
Form 3
Initial statement of beneficial ownership of securities  
09/30/2025 7:35 AM
Biofrontera (1858685) Issuer
Plaggemars Hansjoerg (2088823) Reporting
Form 3
Initial statement of beneficial ownership of securities  
09/26/2025 3:49 PM
Biofrontera (1858685) Issuer
DEUTSCHE BALATON AKTIENGESELLSCHAFT (1571071) Reporting
Form 3
Initial statement of beneficial ownership of securities  
09/26/2025 3:59 PM
Biofrontera (1858685) Issuer
Zours Wilhelm Konrad Thomas (1571015) Reporting
Form 3
Initial statement of beneficial ownership of securities  
09/25/2025 2:23 PM
Biofrontera (1858685) Issuer
de la Huerta Martinez Maria del Pilar (2084869) Reporting
Form 3
Initial statement of beneficial ownership of securities  
09/19/2025 3:45 PM
Biofrontera (1858685) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/19/2025 2:04 PM
Biofrontera (1858685) Subject
DEUTSCHE BALATON AKTIENGESELLSCHAFT (1571071) Filed by
Form SCHEDULE 13D/A
09/18/2025 10:59 AM
Biofrontera AG (1712641) Reporting
Biofrontera (1858685) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2025 8:19 PM
Biofrontera (1858685) Issuer
Leffler Eugene Frederick (1952347) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2025 8:21 PM
Biofrontera (1858685) Issuer
Luebbert Hermann (1886492) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2025 8:22 PM
Biofrontera (1858685) Issuer
Weber Kevin Daniel (1916746) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2025 8:23 PM
Biofrontera (1858685) Issuer
Jones George Patrick (2085560) Reporting
Form 3
Initial statement of beneficial ownership of securities  
09/16/2025 8:25 PM
Biofrontera (1858685) Issuer
Jones George Patrick (2085560) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2025 8:15 PM
Biofrontera (1858685) Issuer
BORER JOHN J III (1406217) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
Your $29.97 book is free today (Ad)

Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options can give you up to 12 times the leverage of stocks — with a fraction of the capital tied up. This free guide lays it all out in plain English — from A to Z, with step-by-step examples you can follow in your own account.tc pixel

Normally $29.97. Today it's free. Grab your copy now.
09/16/2025 8:17 PM
Biofrontera (1858685) Issuer
Hoffman Beth J. (1885321) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2025 8:18 PM
Biofrontera (1858685) Issuer
Lanckriet Heikki (1990267) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2025 11:15 PM
Biofrontera (1858685) Filer
Form EFFECT
08/13/2025 4:22 PM
Biofrontera (1858685) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2025 4:30 PM
Biofrontera (1858685) Filer
Form S-1/A
08/11/2025 4:10 PM
Biofrontera (1858685) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/11/2025 12:57 PM
Biofrontera (1858685) Subject
Rosalind Advisors, Inc. (1622627) Filed by
Form SCHEDULE 13G/A
07/25/2025 1:31 PM
Biofrontera (1858685) Subject
DEUTSCHE BALATON AKTIENGESELLSCHAFT (1571071) Filed by
Form SCHEDULE 13D/A
07/16/2025 4:28 PM
Biofrontera (1858685) Filer
Form S-1
Registration statement under Securities Act of 1933  
07/11/2025 4:21 PM
Biofrontera (1858685) Filer
Form D
Notice of Exempt Offering of Securities 
07/09/2025 1:56 PM
Biofrontera AG (1712641) Reporting
Biofrontera (1858685) Issuer
Form 3
Initial statement of beneficial ownership of securities  
07/01/2025 7:55 AM
Biofrontera (1858685) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/30/2025 7:05 AM
Biofrontera (1858685) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/18/2025 3:15 PM
Biofrontera (1858685) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2025 2:00 PM
Biofrontera (1858685) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2025 4:15 PM
Biofrontera (1858685) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2025 2:27 PM
Biofrontera (1858685) Subject
LYTTON LAURENCE W (1105806) Filed by
Form SCHEDULE 13G/A
(Data available from 1/1/2016 forward)

Biofrontera SEC Filings - Frequently Asked Questions

Biofrontera (BFRIW) has submitted 217+ filings to the SEC since 2021. You can browse the complete history or filter by form type using the tools above.

The most recent filing was a Form 8-K submitted on May 14, 2026. This was a current report on a material business event.

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


This page (NASDAQ:BFRIW) was last updated on 5/15/2026 by MarketBeat.com Staff.
From Our Partners